Controlled irreversible electroporation
First Claim
Patent Images
1. A method of targeting cancer cells, comprising the steps of:
- (a) identifying cancer cells to be ablated in a target area, wherein the target area comprises heterogenous tissue comprising nerve tissue surrounded by myelin layers;
(b) placing a first electrode and a second electrode such that the target area is positioned between the first and second electrodes;
(c) applying electrical pulses between the first and second electrodes in an amount which compensates for tissue heterogeneity, and is sufficient to irreversibly electroporate the cancer cells in the target area;
wherein voltage, wattage and duration of the electrical pulses are maintained within ranges which avoid damage to the nerve tissue in the target area; and
(d) monitoring temperature of the heterogeneous tissue and adjusting the electrical pulses to maintain the temperature at 50°
C. or less for a period of time that avoids thermal damage to cells of the heterogeneous tissue.
1 Assignment
0 Petitions
Accused Products
Abstract
Electrical pulses are applied to tissue in a manner which destroys targeted cells such as cancerous cells while sparing non-targeted cells such as nerve cells. The electrical pulses are controlled within ranges for voltage, wattage and duration of application. Multiple pulses or groups of pulses may be applied to obtain a desired result while maintaining any temperature increase below a level which destroys cells.
147 Citations
14 Claims
-
1. A method of targeting cancer cells, comprising the steps of:
-
(a) identifying cancer cells to be ablated in a target area, wherein the target area comprises heterogenous tissue comprising nerve tissue surrounded by myelin layers; (b) placing a first electrode and a second electrode such that the target area is positioned between the first and second electrodes; (c) applying electrical pulses between the first and second electrodes in an amount which compensates for tissue heterogeneity, and is sufficient to irreversibly electroporate the cancer cells in the target area;
wherein voltage, wattage and duration of the electrical pulses are maintained within ranges which avoid damage to the nerve tissue in the target area; and(d) monitoring temperature of the heterogeneous tissue and adjusting the electrical pulses to maintain the temperature at 50°
C. or less for a period of time that avoids thermal damage to cells of the heterogeneous tissue. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A method of targeting cancer cells, comprising the steps of:
-
(a) identifying cancer cells to be ablated in a target area, wherein the target area comprises heterogeneous tissue comprising nerve tissue surrounded by myelin layers; (b) placing a first electrode and a second electrode such that the target area is positioned between the first and second electrodes; and (c) monitoring temperature of the heterogeneous tissue and adjusting electrical pulses from the first and second electrodes to ablate the cancer cells without damaging the nerve tissue, and maintain temperature at 50°
C. or less for a period of time thereby avoiding thermal damage to cells of the heterogeneous tissue. - View Dependent Claims (8, 9, 10)
-
-
11. A method of ablating cancer cells, comprising the steps of:
-
(a) identifying cancer cells to be ablated in a target area, wherein the target area comprises heterogeneous tissue comprising nerve tissue surrounded by myelin layers; (b) placing a first electrode and a second electrode such that the target area is positioned between the first and second electrodes; and (c) monitoring temperature of the heterogeneous tissue and adjusting electrical pulses from the first and second electrodes to ablate the cancer cells without damaging the nerve tissue, and maintain temperature at 50°
C. or less for a period of time that avoids thermal damage to cells of the heterogeneous tissue, wherein the first electrode and second electrode are circular in shape; andwherein the first and second electrodes are positioned within less than 2 cm of each other. - View Dependent Claims (12, 13, 14)
-
Specification